< Back to previous page
Researcher
Rene Westhovens
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → Today
Projects
1 - 9 of 9
- The Future of Early Rheumatoid Arthritis Management: From Disease Control to Patient WellbeingFrom1 Oct 2018 → 31 Oct 2021Funding: FWO fellowships
- Spondyloarthritis in Kinshasa, DR Congo: Epidemiology, phenotype, immunogenetic, clinical diagnosis and management.From24 Jul 2018 → 24 Jul 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Validation of PROMIS item banks in Flemish patients with Rheumatoid Arthritis.From1 Nov 2017 → 31 Oct 2018Funding: Other federal public and semi-governmental institutions
- Unmet needs in early Rheumatoid Arthritis: lessons from the CareRA studyFrom1 Oct 2016 → 18 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Sensor-based Platform for the Accurate and Remote monitoring of Kine(ma)tics Linked to E-health (SPARKLE).From1 Oct 2014 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
- The impact of illness perceptions on health outcomes in patients with multisystem diseasesFrom1 Mar 2013 → 31 Oct 2015Funding: Other federal public and semi-governmental institutions
- TOWARDS IMPLEMENTATION OF INTENSIVE COMBINATION TREATMENT STRATEGIES FOR EARLY RHEUMATOID ARTHRITISFrom1 Oct 2011 → 31 Dec 2015Funding: Private funding of national origin - undefined
- Towards a better understanding of functioning in patients with axial spondyloarthritis: an application of the International Classification of Functioning, Disability and Health (ICF) modelFrom1 Nov 2010 → 28 Jun 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Transfer and transition of adolescents and young adults with juvenile idiopathic arthritisFrom1 Oct 2008 → 5 Jul 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 422
- New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 108 - 115 - Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial(2022)
Authors: Delphine Bertrand, Diederik De Cock, Michaël Doumen, Rene Westhovens, Patrick Verschueren
Pages: 470 - 480 - Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
- Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 1385 - 1391 - Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020)(2022)
Authors: Paul De Munter, Bénédicte Dubois, Rene Westhovens
- Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis(2022)
Authors: Rene Westhovens, Michaël Doumen, Delphine Bertrand, Patrick Verschueren
Pages: 3101 - 3103 - Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes(2022)
Authors: Rene Westhovens
- Pericarditis as a manifestation of IgG4-related disease(2022)
Authors: Michaël Doumen, Rene Westhovens
Pages: 1287 - 1295 - Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis(2022)
Authors: Patrick Verschueren, Rene Westhovens
Pages: 937 - 943 - AN ECONOMIC WINDOW OF OPPORTUNITY FOR PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 5-YEAR COST-EFFECTIVENESS ANALYSIS OF THE CARERA TRIAL(2022)
Authors: Michaël Doumen, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 23 - 24